NICE’s Preparations for Evaluating New Al...

By HEOR Staff Writer

December 27, 2023

The Advent of Disease-Modifying Dementia Treatments (DMDTs) Recent years have seen significant strides in our understanding of dementia, particularly
The Future of Clinical Trials: A Shift from Artificial to Augmented to Applie...
Reassessing the Impact of Demographic Representation on Clinical Development ...
The Power of Public Health: A Look at South Africa’s HIV Treatment Prog...
Addressing the Disparity: Treating Childhood Cancer in Low and Middle-Income ...
Pioneering Treatments for Paroxysmal Nocturnal Hemoglobinuria
A New Dawn in Breast Cancer Treatment: Ultra-Hypofractionated Radiotherapy
Machine Learning for the Pharmaceutical Sector: The Beginning of a Uprising i...
Spinal Muscular Atrophy: A Comprehensive Review of Newborn Screening, Treatme...
Igniting Drug Discovery in Africa: A Renewed Partnership
The Value-Based Pricing and Market Access of Valbenazine: A Cost Effective Ev...
Navigating the Maze: The EU Pharma Legislation Review and its Implications
The Unapproved Fixed-Dose Combination Drugs in India: A Public Health Concern